StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > So much excitement!!

<< Previous

Bullboard Posts

Next >>

Comment by gojotv!on Apr 13, 2021 6:57am

194 Views

Post# 32983414

RE:RE:So much excitement!!

If the directors of "Health Clinics Ltd." in London have retained Middle-Eastern clients from their past partnerships with Saudi and U.A.E. directors, the Aristotle test could very quickly find traction in that part of the world.
In Saudi Arabia, women are examined by male doctors through a hole in a blanket...I can't imagine that too many women feel comfortable getting pap tests or mammograms.
Aristotle is the perfect diagnostic tool for women in this culture, giving them a fast, non-invasive, far less embarrassing suite of tests which could detect cancers early and save families.
And with Telehealth, they can get cancer support treatment either in the U.K. or at home. This is a very wealthy market that would gladly travel to London for the best healthcare.
I have no doubt they see the potential already, especially if they've served U.K. non-residents in the past.

gojotv! wrote: When you look into "Health Clinics, Ltd." you quickly find out that a couple of past directors are connected to Saudi Arabia and the United Arab Emirates!
Wow!
If we tap into that clientele, Aristotle will fly off the shelves! They'd think nothing of a multi-cancer screen that's minimally invasive, time-efficient, and priced at a mere $1500!
And think of Emirates Airline!
Telehealth would be perfect for their flight crew!
There's so much potential here!
(That Clarus analyst got it wrong, we know, because employers ARE in under the new plan, but I don't think he realizes where this could lead...!)
Happy Monday! I predict a nice gap up!

gojotv! wrote: Nearly 100 posts on this board ON A SUNDAY!!
And the day's not over yet!
Bashers are falling all over themselves trying to keep the price of this juggernaut down.
Confusion over the acquisition is clearing.
Shareholders are beginning to realize that "Health Clinics UK" has a powerhouse team of directors eager to implement the universal adoption of Aristotle in Europe and the U.S.!!
The more you know, the more these basher clowns will make you laugh!
Gap up tomorrow, and on from there!
Wheeeeee!!